Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

DBV Technologies

Tracked across 6 events · 37 articles · First seen Apr 02, 2026 · Last active Jul 06, 2026

Sentiment
8
Attention
3
Events
6
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
3 40
Tech
Impact: DBV Technologies announced the screening of the first participant in its THRIVE Phase 2 clinical study for the VIASKIN Peanut Patch, which could significantly advance its product pipeline and market position if successful.
Jun 02, 2026 · 6 articles
1 0
Regulatory
Impact: DBV Technologies is the company issuing the regulatory filing regarding its total number of shares and voting rights.
Apr 02, 2026 · 7 articles
2 10
Business
Impact: DBV Technologies will participate in the Goldman Sachs 47th Annual Global Healthcare Conference, providing an opportunity to present its developments and potentially attract investor interest.
Jun 05, 2026 · 6 articles
0 0
Business
Impact: DBV Technologies is the issuer of the liquidity contract report, which is a routine disclosure. The report shows increased share holdings in the liquidity account but no significant change in market perception.
Jul 06, 2026 · 6 articles
2 0
Business
May 12, 2026 · 6 articles
1 0
Business
May 13, 2026 · 6 articles
Euronext Paris DBV Technologies
Euronext Paris DBV Technologies
ERGEN INTELLIGENCE
Track DBV Technologies live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.